May 7, 2020 / 12:26 PM / a month ago

BRIEF-Albireo Pharma Q1 Loss Per Share $2.23

Albireo Pharma Inc:

* ALBIREO REPORTS Q1 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 REVENUE ESTIMATE $1 MILLION — REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE ESTIMATE $-1.37 — REFINITIV IBES DATA

* COMMERCIAL PREPARATIONS ADVANCING, WITH TOPLINE PEDFIC 1 RESULTS EXPECTED MID-2020

* FUNDAMENTALS REMAIN UNCHANGED

* CONTINUE TO MAKE SIGNIFICANT PROGRESS ACROSS DEVELOPMENT PROGRAMS

* PRIOR GUIDANCE REGARDING CLINICAL TRIALS REMAINS UNCHANGED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below